Is JAGX or JAZZ more undervalued in 2026?

CirclFi compares Jaguar Health, Inc. (JAGX) and Jazz Pharmaceuticals plc (JAZZ) using 13 institutional-grade valuation models. JAGX has a Quality of Company score of 4.2/10 while JAZZ scores 7.5/10.

Which is a better buy — JAGX or JAZZ?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do JAGX and JAZZ valuations compare?

JAGX at $3.55 and JAZZ at $236.49 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

JAGX vs JAZZ Valuation Comparison 2026 — Intrinsic Value Analysis

JAGX

Pharmaceutical Preparations

Jaguar Health, Inc.

Quality

4.2

out of 10

Value Trap

WARN

Price

$3.55

Last close

Models

4/13

Active

JAZZ

Pharmaceutical Preparations

Jazz Pharmaceuticals plc

Quality

7.5

out of 10

Value Trap

SAFE

Price

$236.49

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	JAGX Fair Value	JAGX Upside	JAZZ Fair Value	JAZZ Upside
Bayesian DCF	Intrinsic	—	—	$352.09	+48.9%
EROIC Spread	Intrinsic	—	—	$108.93	-44.6%
First Chicago	Scenario	$4.44	+27.9%	$63.43	-73.5%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.66	-90.2%	$34.16	-85.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for JAGX vs JAZZ — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

JAGX vs JAZZ — Which Stock Is More Undervalued?

JAZZ scores higher with a 7.5/10 quality rating vs JAGX's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Jaguar Health, Inc. (JAGX) and Jazz Pharmaceuticals plc (JAZZ) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

JAGX currently trades at $3.55 with a QOC of 4.2/10, while JAZZ trades at $236.49 with a QOC of 7.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).